Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Angela Frentzen"'
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Several novel MHC class I epitope prediction tools additionally incorporate the abundance levels of the peptides’ source antigens and have shown improved performance for predicting immunogenicity. Such tools require the user to input the MHC allele
Externí odkaz:
https://doaj.org/article/08492a75c0094fa2a383671cbac795f1
Autor:
Zeynep Koşaloğlu-Yalçın, Manasa Lanka, Angela Frentzen, Ashmitaa Logandha Ramamoorthy Premlal, John Sidney, Kerrie Vaughan, Jason Greenbaum, Paul Robbins, Jared Gartner, Alessandro Sette, Bjoern Peters
Publikováno v:
OncoImmunology, Vol 7, Iss 11 (2018)
Epitopes that arise from a somatic mutation, also called neoepitopes, are now known to play a key role in cancer immunology and immunotherapy. Recent advances in high-throughput sequencing have made it possible to identify all mutations and thereby a
Externí odkaz:
https://doaj.org/article/f002e162cd5349459e9d923e4a132145
Autor:
Zhiqin Huang, Pramod K. Srivastava, Song Liu, Jason A. Greenbaum, Dirk Jäger, Jiaqian Wang, Ognjen Milicevic, Willem-Jan Krebber, Barbara Schrörs, Sean Michael Boyle, Michal Bassani-Sternberg, Ana M. Mijalkovic Lazic, Amit A. Lugade, Kristen K. Dang, Han Si, Alessandro Sette, Jeffrey P. Ward, Irsan Kooi, Michael F. Princiotta, Begonya Comin-Anduix, Thierry Schuepbach, Pia Kvistborg, Julia Kodysh, William Chour, Vladimir B. Kovacevic, Jan H. Kessler, Ariella Sasson, Antoni Ribas, Brian Stevenson, Sriram Sridhar, Prateek Tanden, Robert D. Schreiber, Jason Perera, Kathleen C. F. Sheehan, Hira Rizvi, Sachet A. Shukla, Baikang Pei, Han Chang, Bo Li, Ion I. Mandoiu, Cristina Puig-Saus, Beatriz M. Carreno, Si Qiu, Jennifer M. Shelton, Patrick Jongeneel, Qiang Hu, Taha Merghoub, Matthew D. Hellmann, James P. Conway, Francisco Arcila, Ton N. Schumacher, Mathias Vormehr, Christopher A. Morehouse, Patrice Manning, Jonathon Blake, Pornpimol Charoentong, Angela Frentzen, Christopher A. Miller, Michael A. Kuziora, Bin Song, Lei Wei, Martin Löwer, Gabor Bartha, Justin Guinney, Niels Halama, Rolf Hilker, Yinong Sebastian, Veliborka Josipovic, Jason Harris, Geng Liu, Guilhem Richard, Arjun A. Rao, Nikola M. Skundric, Markus Mueller, Daniel K. Wells, Tatiana Shcheglova, Inka Zörnig, Weixuan Fu, John Sidney, Nadine Defranoux, Gabriela Steiner, Joseph D. Szustakowski, Arbel D. Tadmor, Maxim N. Artyomov, Jianmin Wang, George Coukos, Brandon W. Higgs, Milica R. Kojicic, Siranush Sarkizova, Daphne van Beek, Naibo Yang, Robert Ziman, Mignonette H. Macabali, Thomas Yu, Nicolas Guex, Nina Bhardwaj, Lorenzo F. Fanchi, Bjoern Peters, Christian Iseli, Song Wu, Maren Lang, Juliet Forman, Marit M. van Buuren, David Balli, Steven L. C. Ketelaars, Nir Hacohen, Ekaterina Esaulova, Maarten Slagter, Todd Creasy, Robert A. Petit, Yi-Hsiang Hsu, Ravi Gupta, Katie M. Campbell, Pascal Gellert, David Haussler, Jesse M. Zaretsky, Sofie R. Salama, Vanessa M. Hubbard-Lucey, Joel Greshock, Zeynep Kosaloglu Yalcin, Cornelis J. M. Melief, Priyanka Shah, Ioannis Xenarios, Nevena M. Ilic Raicevic, Andrew Lamb, Suchit Jhunjhunwala, Aly A. Khan, David Gfeller, James R. Heath, Richard Chen, Jia M. Chen, Alphonsus H. C. Ng, Elham Sherafat, Ana Belen Blazquez, Leo J. Lee, Beata Berent-Maoz, Cheryl Selinsky, Jasreet Hundal, Eduardo Cortes, Xengie Doan, Sahar Al Seesi, Adam Kolom, Fred Ramsdell, Nicolas Robine, Andrew J. Rech
Many approaches to identify therapeutically relevant neoantigens couple tumor sequencing with bioinformatic algorithms and inferred rules of tumor epitope immunogenicity. However, there are no reference data to compare these approaches, and the param
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b788124c42a6ace5b9cb5efa2f3572c
https://resolver.caltech.edu/CaltechAUTHORS:20201019-121956456
https://resolver.caltech.edu/CaltechAUTHORS:20201019-121956456
Autor:
Ezra E.W. Cohen, Bjoern Peters, Milad Bahmanof, Kim McConnell, Angela Frentzen, Roxanne Habbaba, Leslie Montero, Jason A. Greenbaum, Luise Westernberg, Ashmitaa Logandha Ramamoorthy Premlal, Zeynep Kosaloglu-Yalcin, Aaron M. Miller, Grégory Seumois, Elaine Eng, Alessandro Sette, Amanda Natsuhara, Stephen P. Schoenberger
Publikováno v:
Journal of Clinical Oncology. 39:2615-2615
2615 Background: Neoantigens (NeoAg) are key targets for personalized immunotherapy but efficient methods for their systematic identification and therapeutic targeting remain elusive. We developed a methodology to reliably identify and verify somatic
Autor:
Paul D. Robbins, Zeynep Kosaloglu-Yalcin, Angela Frentzen, Kerrie Vaughan, Bjoern Peters, Jason A. Greenbaum, Ashmitaa Logandha Ramamoorthy Premlal, Manasa Lanka, Jared J. Gartner, John Sidney, Alessandro Sette
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 7, Iss 11 (2018)
OncoImmunology, Vol 7, Iss 11 (2018)
Epitopes that arise from a somatic mutation, also called neoepitopes, are now known to play a key role in cancer immunology and immunotherapy. Recent advances in high-throughput sequencing have made it possible to identify all mutations and thereby a
Autor:
Zeynep Kosaloglu-Yalcin, Angela Frentzen, Ashmitaa Logandha Ramamoorthy Premlal, Jason Greenbaum, Alessandro Sette, Bjoern Peters
Publikováno v:
Cancer Research. 79:3374-3374
Mutations acquired during oncogenesis can result in so-called neoantigens, i.e. mutation-bearing peptides that have the potential to be bound by HLA molecules and recognized by T cells. Neoantigens were suggested to be crucial for the outcome of immu
Autor:
Martin Souren Naradikian, Leslie Montero, Samantha Hall, Rukman Thota, Angela Frentzen, Milad Bahmanof, Luise Sternberg, Jerome Lane, Zeynep Kosaloglu-Yalcin, Manasa Lanka, Aaron Miller, Bjoern Peters, Ezra Cohen, Stephen Schoenberger
Publikováno v:
The Journal of Immunology. 202:134.1-134.1
Neoantigens (NeoAg) offer attractive therapeutic targets for directing a patient’s immune response to the immunogenic subset of mutations expressed exclusively by their cancer cells. Despite the specificity with which NeoAg enable tumor recognition
Autor:
Zeynep Kosaloglu Yalcin, Angela Frentzen, Ashmitaa Logandha Ramamoorthy Premlal, John Sidney, Jason A Greenbaum, Alessandro Sette, Bjoern Peters
Publikováno v:
The Journal of Immunology. 202:70.16-70.16
Neoantigens were suggested to be crucial for the outcome of immune checkpoint blockade (ICB) therapies and accordingly, the neoantigen load of a tumor is often being used to predict therapy outcome. Current approaches utilize HLA binding predictions